Literature DB >> 22976173

Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulations.

Ethan M Stier1, Barbara M Davit, Parthapratim Chandaroy, Mei-Ling Chen, Jeanne Fourie-Zirkelbach, Andre Jackson, Stephanie Kim, Robert Lionberger, Mehul Mehta, Ramana S Uppoor, Yaning Wang, Lawrence Yu, Dale P Conner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22976173      PMCID： PMC3475859          DOI： 10.1208/s12248-012-9397-7

Source DB:  PubMed          Journal:  AAPS J        ISSN： 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  4 in total

1.  Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary report.

Authors:  Mei-Ling Chen; Vinod P Shah; Derek Ganes; Kamal K Midha; James Caro; Prabu Nambiar; Mario L Rocci; Avinash G Thombre; Bertil Abrahamsson; Dale Conner; Barbara Davit; Paul Fackler; Colm Farrell; Suneel Gupta; Russell Katz; Mehul Mehta; Sheldon H Preskorn; Gerard Sanderink; Salomon Stavchansky; Robert Temple; Yaning Wang; Helen Winkle; Lawrence Yu
Journal:  AAPS J       Date:  2010-05-04       Impact factor: 4.009

Review 2.  Using partial area for evaluation of bioavailability and bioequivalence.

Authors:  Mei-Ling Chen; Barbara Davit; Robert Lionberger; Zakaria Wahba; Hae-Young Ahn; Lawrence X Yu
Journal:  Pharm Res       Date:  2011-04-13       Impact factor: 4.200

3.  Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity.

Authors:  J Swanson; M Kinsbourne; W Roberts; K Zucker
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

4.  A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Authors:  James M Swanson; Sharon B Wigal; Tim Wigal; Edmund Sonuga-Barke; Laurence L Greenhill; Joseph Biederman; Scott Kollins; Annamarie Stehli Nguyen; Heleen H DeCory; Sharon J Hirshe Dirksen; Simon J Hatch
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124
  4 in total
  3 in total

1.  The Two Main Goals of Bioequivalence Studies.

Authors:  Laszlo Endrenyi; Henning H Blume; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2017-02-02       Impact factor: 4.009

2.  Impact of release mechanism on the pharmacokinetic performance of PAUC metrics for three methylphenidate products with complex absorption.

Authors:  Andre Jackson
Journal:  Pharm Res       Date:  2013-08-07       Impact factor: 4.200

3.  Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder.

Authors:  Nathan S Teuscher; Akwete Adjei; Robert L Findling; Laurence L Greenhill; Robert J Kupper; Sharon Wigal
Journal:  Drug Des Devel Ther       Date:  2015-05-26       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.